|
Effective on august 1, 2026, mdr-related activities and responsibilities were transferred to pentax medical corporation as part of a corporate restructuring.This report is being submitted by pentax medical corporation.In accordance with 21 cfr 803.3(m), because this corporate restructuring does not affect the manufacturing site, the fda registration number previously assigned for this site (#9610877) continues to be used.The product was returned to pentax medical for repair: our technician checked the returned unit and confirmed that the objective gluing missing.Based on the result, we concluded that it was caused due to the physical damage applied on the objective gluing.As a result of confirming the detail a gfe, no response was obtained, so we cannot deny the possibility of the glue falls.Therefore, based on the technical report "hr-rpt-0974 (distal end)" and/or the risk analysis results, it was evaluated to submit mdr.
|